COMMUNIQUÉS West-GlobeNewswire

Positive New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented in Global Webcast

30/05/2018 - 14:00

New data presented shows ORR of 61% (11/18 patients) SYDNEY, Australia, May 30, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) ("Immutep“ or “the Company“), a biotechnology company developing novel [...]

Immunomedics to Present at Jefferies 2018 Global Healthcare Conference

30/05/2018 - 14:00

MORRIS PLAINS, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”), a science-based and innovation-focused biopharmaceutical company committed to the development [...]

TRACON Pharmaceuticals Appoints Biotech Industry Veteran Mark Wiggins as Chief Business Officer

30/05/2018 - 14:00

Mr. Wiggins Brings Over 30 Years of Business Development and Commercial Experience in Biotech to TRACON SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a biopharmaceutical company [...]

Tonix Pharmaceuticals to Present at the 2018 BIO International Convention

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present an overview [...]

Allena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference

30/05/2018 - 14:00

NEWTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme [...]

Humanigen CEO to Present at 8th Annual LD Micro Invitational

30/05/2018 - 14:00

BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company developing cutting-edge T-cell optimization and oncology treatments, today announced that Cameron Durrant, M [...]

Ovid Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference on June 8, 2018

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

BioSyent Releases Results for Q1 2018

30/05/2018 - 14:00

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three months ended March 31, 2018. Key highlights include: First quarter ( [...]

K2M Receives FDA Clearance for BACS® Patient-Specific Module

30/05/2018 - 14:00

Surgeon-tailored rods, rails, and templates to treat spinal deformity LEESBURG, Va., May 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine [...]

ContraVir Pharmaceuticals’ Cyclophilin Inhibitor, CRV431, Reduces Development and Progression of Liver Tumors in Preclinical Hepatocellular Carcinoma Study

30/05/2018 - 14:00

EDISON, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Spectral Provides Corporate Update

30/05/2018 - 14:00

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT ), a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 14:00

BURLINGTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]

RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018

30/05/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

PolarityTE to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 14:00

SALT LAKE CITY, May 30, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (Nasdaq: COOL ) today announced it will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 2:30pm ET. Denver M. [...]

Selecta Biosciences to Present at the Jefferies Global Healthcare Conference on June 06, 2018

30/05/2018 - 14:00

WATERTOWN, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

BeyondSpring Announces $20 Million Registered Direct Offering

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring”), a global, clinical-stage biopharmaceutical company focused on the development and commercialization of innovative cancer [...]

Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 13:00

HOUSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering ESKATA

30/05/2018 - 13:00

Issuance of U.S. Patent No. 9,980,983 Further Strengthens Aclaris’ ESKATA™ Patent Portfolio WAYNE, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical [...]

Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer

30/05/2018 - 13:00

BOSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]